Nonconvulsive electrotherapy in psychiatry: The treatment of the mental disorders of the Norwegian painter Edvard Munch

The electrified artist: Edvard Munch's demons, treatments, and sketch of an electrotherapy session (1908-1909)

In 1908-1909, Norwegian artist Edvard Munch (1863-1944), best remembered for The Scream (1893), spent eight months under Daniel Jacobson's care in a private nerve clinic in Copenhagen. Munch was suffering from alcohol abuse, and his signs and symptoms included auditory hallucinations, persecutory delusions, paresthesias, paralyses, violent mood swings, depression, loss of control, fatigue, and the loss of his basic ability to take care of himself. He was treated with rest, a fortifying diet, massages, baths, fresh air, limited exercise, and nonconvulsive electrotherapy. After he had settled in, Jacobson allowed Munch to draw, paint, and engage in photography. Munch responded with a portrait of Jacobson and a small but intriguing sketch of himself at one of his electrotherapy sessions. In this article, we examine the circumstances that brought Munch to Jacobson's clinic and his therapies, with particular attention to electrotherapies. In so doing, we hope to provide a more complete picture of Munch's crisis in 1908, his nerve doctor, the rationales for medical electricity and other treatments he endured, and Scandinavian psychiatry at this moment in time.

Edvard Munch's crisis in 1908 and French medicine: His doctors, treatments, and sources of information

In 1908, Norwegian artist Edvard Munch-already famous for The Scream and other paintings showing sickness, despair, and suffering-put himself under the care of Dr. Daniel Jacobson, a nerve doctor in Copenhagen. Jacobson had previously attended some of Jean-Martin Charcot's lectures in Paris, as had Knud Pontoppidan, his mentor. Munch, in turn, had long been showing signs and symptoms of an anxiety disorder and what might have been viewed as neurasthenia or hysteria. Now, he also seemed to be suffering from acute alcoholic toxicity. In this article, we explore Scandinavian psychiatry at the turn of the century; Jacobson and Pontoppidan's connections to Paris; and how some of Munch's treatments, most notably his electrotherapy sessions, related to therapeutics at La Salpêtrière. Additionally, various ways in which Munch learned about French medicine are examined. This material reveals how well-known and influential Charcot and his ideas about disorders of the brain and mind had become at the turn of the century, affecting not just the French physicians but also a world-famous artist and his nerve doctor in Scandinavia.

The Nomenclature of Electroconvulsive Therapy

ABSTRACT

Electroconvulsive therapy (ECT) is an established but stigmatized psychiatric treatment. The term ECT reflects the treatment's modality and action. Several authors proposed different names for ECT to deal with stigma; however, available literature that promoted different names did not address the risk/benefit ratio or offer evidence-based approach to the efficacy of this approach. We aim to examine proposed names for their specificity, accuracy, understandability, and popularity. In addition, we aim to find evidence-based methods to combat the ECT-related stigma. We reviewed the literature relating to the proposed names using snowballing technique for literature search. Known ECT alternative names were used for search, and whenever another name appears, it was added to our search list. We conducted Medline, PsycINFO, Google Scholar, and PubMed search to check for popularity and cross examine whether proposed terms refer back to ECT. We searched for ECT and stigma, to find evidence for methods to tackle ECT-related stigma. Once, the search stopped yielding newer ideas, we stopped the search at a point of saturation, where no more ideas where generated. Our name search yielded 14 terms. Nine names avoided "electricity" and "convulsion," because of perceived associated stigma. Presence of different terminology can affect the clarity of patient-doctor communication, with no evidence of added benefit. Alternative names may affect doctor-doctor communication about this treatment. We concluded that it is safer to retain the term ECT for the sake of consistency and clarity of communication. Education and experience are evidence-based effective methods of tackling ECT-related stigma.

A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression

Nonconvulsive electrotherapy (NET) defined as electrical brain stimulation administered like standard electroconvulsive therapy (ECT), but below seizure threshold, could be effective for patients with treatment-refractory depression (TRD) with fewer adverse neurocognitive outcomes. However, there is a lack of studies in Chinese patients with TRD. Thus, this study was conducted to examine the efficacy and safety of adjunctive NET for Chinese patients with TRD. Twenty TRD patients were enrolled and underwent six NET treatments. Depressive symptoms, response, and remission were assessed with the 17-item Hamilton Depression Rating Scale (HAMD-17) at baseline and after 1, 3, and 6 NET treatments. Neurocognitive function was assessed by the Wisconsin Card Sorting Test (WCST) at baseline and after the completion of six NET treatments. Mean HAMD-17 scores declined significantly from 26.2 to 10.4 (p < 0.001) after post-NET. The rates of response and remission were 60.0% (95% CI: 36.5-83.5) and 10.0% (95% CI: 0-24.4), respectively. Neurocognitive performance improved following a course of NET. No significant association was found between changes in depressive symptoms and baseline neurocognitive function. Adjunctive NET appeared to be effective for patients with TRD, without adverse neurocognitive effects. Randomized controlled studies were warranted to confirm these findings.